Health inequities and research gaps for bladder cancer in the United States: A scoping review

Introduction/Objectives: Bladder cancer is a significant health issue in the United States, with over 83,000 new cases and nearly 17,000 deaths annually. The survival rate varies widely, with a 5-year relative survival rate of 78%, dependent on factors like disease stage at diagnosis. Despite established risk factors, health inequities persist, disproportionately affecting marginalized populations. Although health inequities research has grown, healthcare access remains inequitable, with race, ethnicity, and socioeconomic status serving as key determinants of health outcomes. This scoping review seeks to examine gaps in health inequity research for bladder cancer.